Skip to main content

Table 4 Dimensions and reporting of implementation dose

From: Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial

Intervention dose dimensions

Description

Measurement

Intervention period

Sustainment period

Quantity

# CQI micro-interventions by facility

Reports

Reports

Exposure

# TA visits to facilities

Reports

Reports

Intensity

Depth of use of the SAIA-HTN at the facility

FGD/IDI

FGD/IDI

Scope

Breadth of use of SAIA-HTN at the facility (comprehensiveness)

FGD/IDI

FGD/IDI

Reach

# Health workers/patients touched by the intervention

Reports

Reports

Engagement

Commitment/seriousness of staff participating in the intervention

FGD/IDI

FGD/IDI

Duration

Amount of time SAIA-HTN was actively used within a site

Reports

Reports

Quality

Quality of SAIA-HTN implementation over time (complete reporting, iterative cycles, data use)

Reports and FGD/IDI

Reports and FGD/IDI

  1. CQI continuous quality improvement, TA technical advisor; FGD focus group discussions, IDI in-depth interviews